This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kaste, M. Search for Related Content PubMed Articles by Kaste, M. Related Collections Other Ethics and Policy Acute Cerebral Infarction Emergency treatment of Stroke Computerized tomography and Magnetic Resonance Imaging Thrombolysis

(Stroke. 2001;32:2717.)
© 2001 American Heart Association, Inc.

Comments, Opinions, and Reviews

Thrombolysis for Acute Ischemic Stroke

A Consensus Statement of the 3rd Karolinska Stroke Update, October 30–31, 2000

Markku Kaste, MD, Chair; Lars Thomassen, MD, Co-Chair; Martin Grond, MD; Werner Hacke, MD; Stig Holtås, MD; Richard I. Lindley, MD; Risto O. Roine, MD; Nils Gunnar Wahlgren, MD; Joanna M. Wardlaw, MD on behalf of the participants of the 3rd Karolinska Stroke Update, October 30–31, 2000

From the Department of Neurology, Helsinki University Central Hospital, University of Helsinki, Helsinki, Finland (M.K., R.O.R.); Department of Neurology, Haukeland Hospital, University of Bergen, Bergen, Norway (L.T.); Kreiskrankenhaus, Siegen, Germany (M.G.); Department of Neurology, University of Heidelberg, Heidelberg, Germany (W.H.); Department of Radiology, University of Lund, Lund, Sweden (S.H.); Department of Clinical Neurosciences, Western General Hospital NHS Trust, University of Edinburgh, Edinburgh, UK (R.I.L., J.M.W.); and Department of Neurology, Karolinska Hospital, Stockholm, Sweden (N.G.W.).Correspondence to Markku Kaste, MD, Department of Neurology, Helsinki University Central Hospital, University of Helsinki, PO Box 340, FIN-00029 HUS Helsinki, Finland. E-mail markku.kaste@hus.fi

Key Words: stroke management • stroke, acute • stroke, ischemic • thrombolysis

An extract of the first 250 words of the full text is provided, because this article has no abstract.

	Introduction

 
Karolinska Stroke Update is an annual meeting of European stroke experts. The agenda includes a few important topics in which major progress has occurred or in which there is a need for a European consensus in prevention, acute care, organizing stroke services, and any other field of stroke management. The program committee selects the topics. The meeting is well attended. Thrombolysis in ischemic stroke within 3 hours from the onset of symptoms is evidence-based medicine. So far, only the German Health Authorities have approved it; the approval by the Health Authorities of the European Commission is still pending. While waiting for their decision, the program committee came to the conclusion that there is a need for a consensus statement to make thrombolysis in acute ischemic stroke more widely and safely available in Europe. Accordingly, they selected thrombolysis in stroke as the key topic of the Karolinska Stroke Update 2000.

The writing group nominated by the program committee drafted a preliminary consensus statement before the meeting. The draft was rewritten during the meeting on the basis of feedback provided by the participants. This revised draft was presented to the participants at a general session on the second day of the meeting. The consensus statement was revised at this session point by point until all participants representing experimental and clinical stroke scientists, clinicians treating stroke patients, lay people, and industry could approve the final wording. The participants of the meeting hope that the consensus statement will standardize the use of thrombolysis in . . . [Full Text of this Article]

This article has been cited by other articles:

				J. B. Tatro Melanocortins Defend their Territory: Multifaceted Neuroprotection in Cerebral Ischemia. Endocrinology, March 1, 2006; 147(3): 1122 - 1125. [Full Text] [PDF]

				R. J. Seitz, M. Hamzavi, U. Junghans, P. A. Ringleb, C. Schranz, and M. Siebler Thrombolysis With Recombinant Tissue Plasminogen Activator and Tirofiban in Stroke: Preliminary Observations Stroke, August 1, 2003; 34(8): 1932 - 1935. [Abstract] [Full Text] [PDF]

				B. F. Tomandl, E. Klotz, R. Handschu, B. Stemper, F. Reinhardt, W. J. Huk, K.E. Eberhardt, and S. Fateh-Moghadam Comprehensive Imaging of Ischemic Stroke with Multisection CT RadioGraphics, May 1, 2003; 23(3): 565 - 592. [Abstract] [Full Text] [PDF]